155 results on '"Meek, M.E."'
Search Results
2. Procedural application of mode-of-action and human relevance analysis: styrene-induced lung tumors in mice
3. AOPs in hazard characterization for human health
4. Developing and applying the adverse outcome pathway concept for understanding and predicting neurotoxicity
5. Gaining acceptance for the use of in vitro toxicity assays and QIVIVE in regulatory risk assessment
6. The Assessment and Management of Industrial Chemicals in Canada
7. A user-friendly tool to assess combined exposures to indoor air pollutants in public spaces of children
8. International experience in addressing combined exposures: Increasing the efficiency of assessment
9. Case study illustrating the WHO IPCS guidance on characterization and application of physiologically based pharmacokinetic models in risk assessment
10. Mode of Action/Human Relevance Framework
11. Tools for the prioritization of substances on the Domestic Substances List in Canada on the basis of hazard
12. Problem Formulation for EFSA Scientific Assessments.
13. Foreword: Biomonitoring Equivalents Special Issue
14. New developments in the evolution and application of the WHO/IPCS framework on mode of action/species concordance analysis+
15. Adverse outcome pathways: Application to enhance mechanistic understanding of neurotoxicity
16. Evolution of chemical-specific adjustment factors (CSAF) based on recent international experience; increasing utility and facilitating regulatory acceptance
17. A framework for fit-for-purpose dose response assessment
18. Development of the adverse outcome pathway “alkylation of DNA in male premeiotic germ cells leading to heritable mutations” using the OECD's users' handbook supplement
19. Evolution of mode of action/adverse outcome pathway analyses
20. Using mode of action information to improve regulatory decision-making: An ECETOC/ILSI RF/HESI workshop overview
21. Proposed mode of action of benzene-induced leukemia: Interpreting available data and identifying critical data gaps for risk assessment
22. Risk Assessment Practice for Essential Metals
23. Preface
24. Qualitative Methods for Characterizing Uncertainty in Exposure Assessment
25. Recent developments in frameworks to consider human relevance of hypothesized modes of action for tumours in animals
26. Assessing the dose-dependency of allometric scaling performance using physiologically based pharmacokinetic modeling
27. Releases from copper smelters and refineries and zinc plants in Canada: human health exposure and risk characterization
28. Guidelines for application of chemical-specific adjustment factors in dose/concentration–response assessment
29. Health risk assessment of 1,3-butadiene as a Priority Substance in Canada
30. Categorical Default Uncertainty Factors-Interspecies Variation and Adequacy of Database
31. EVESR RADIOACTIVITY TRANSPORT AND DEPOSITION.
32. IPCS harmonization of risk assessment; Assessment of non-cancer endpoints
33. Relevance of carcinogenicity bioassays in mice in assessing potential health risks associated with exposure to methylene chloride
34. Perceived precision of risk estimates for carcinogenic versus non‐neoplastic effects: Implications for methodology
35. Approach to Health Risk Determination for Metals and Their Compounds under the Canadian Environmental Protection Act
36. Speciation in Health Risk Assessments of Metals: Evaluation of Effects Associated with Forms Present in the Environment
37. Bis(2‐ethylhexyl)phthalate: Evaluation of risks to health from environmental exposure in Canada
38. 1,1,2,2‐Tetrachloroethane: Evaluation of risks to health from environmental exposure in Canada
39. 1,2‐Dichlorobenzene: Evaluation of risks to health from environmental exposure in Canada
40. Chromium and its compounds: Evaluation of risks to health from environmental exposure in Canada
41. Dichloromethane: Evaluation of risks to health from environmental exposure in Canada
42. 3,3'‐Dichlorobenzidine: Evaluation of risks to health from environmental exposure in Canada
43. Pentachlorobenzene: Evaluation of risks to health from environmental exposure in Canada
44. Man‐made vitreous fibres: Evaluation of risks to health from environmental exposure in Canada
45. Di‐n‐Butyl phthalate: Evaluation of risks to health from environmental exposure in Canada
46. Hexachlorobenzene: Evaluation of risks to health from environmental exposure in Canada
47. Benzidine: Evaluation of risks to health from environmental exposure in Canada
48. Cadmium and its compounds: Evaluation of risks to health from environmental exposure in Canada
49. Trichloroethylene: Evaluation of risks to health from environmental exposure in Canada
50. Inorganic fluoride: Evaluation of risks to health from environmental exposure in Canada
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.